- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
COVID vaccination may confound cancer detection through PET imaging: Study
Rochester, MN: PET imaging performed after COVID-19 vaccination showed abnormal radiotracer uptake in the lymph nodes of cancer patients, according to a recent study. There had been no visible axillary node uptake prior to the vaccinations.
The findings, published in the American Journal of Roentgenology, indicate that these alterations in PET findings after the COVID-19 vaccination are important confounding pitfalls that could prompt unnecessary biopsies and treatments unless appropriately recognized by interpreting physicians.
Confounding imaging interpretation, COVID-19 vaccination may trigger reactive lymphadenopathy. However, there has been limited systematic analysis of PET findings after the COVID-19 vaccination. To fill this knowledge gap, Dane G. Schroeder, Mayo Clinic Department of Radiology, Rochester, Minnesota, and colleagues aimed to evaluate the frequency and characteristics of abnormal FDG and 11C-choline uptake on PET imaging performed after COVID-19 vaccination.
For this purpose, the researchers performed a retrospective study of 67 patients who underwent PET examination (PET/CT in 66, PET/MRI in 1; FDG in 54, 11C-choline in 13) between December 14th, 2020 and March 10th, 2021 following COVID-19 vaccination (Pfizer-BioNTech vaccine in 52, Moderna vaccine in 15) and who had undergone pre-vaccination PET without visible axillary node uptake. In patients who had received one (n = 44) and two (n = 23) doses, PET was performed after a median of 13 and 10 days after vaccination.
Key findings of the study include:
- Positive axillary lymph node uptake was observed in 10.4% of patients [7.4% of FDG examinations, 23.1% of 11C-choline examinations]; four and three patients with positive axillary lymph nodes had received Pfizer and Moderna vaccines, respectively.
- Injection laterality was documented in five of seven patients with positive axillary lymph nodes and was ipsilateral to the positive node in all five patients.
- PET was performed within 24 days of vaccination in all patients with a positive node.
- One patient exhibited extra-axillary lymph node uptake (ipsilateral supraclavicular uptake on FDG PET).
- Ipsilateral deltoid uptake was present in 14.5% (8/55) of patients with documented injection laterality, including in 42.9% (3/7) of patients with positive axillary lymph nodes.
- Interreader agreement for SUV measurements ranged from intraclass correlation coefficient of 0.600 to 0.988.
"Our findings demonstrate that increased axillary lymph node or ipsilateral deltoid uptake is occasionally observed on FDG or 11C-choline PET performed after Pfizer-BioNTech or Moderna COVID-19 vaccination," wrote the authors.
"Interpreting physicians should recognize characteristics of abnormal uptake on PET after COVID-19 vaccination to guide optimal follow-up management and reduce unnecessary biopsies," they concluded.
Reference:
The study titled, "Frequency and Characteristics of Nodal and Deltoid FDG and 11C-Choline Uptake on PET Imaging Performed After COVID-19 Vaccination," is published in the American Journal of Roentgenology.
DOI: https://www.ajronline.org/doi/10.2214/AJR.21.25928
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751